ILYA RACHMAN: Open Payments
NPI 1255463204 · RESEDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 12 payments from 6 companies in 2025. Trend: 2023 $1,319 · 2024 $490 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| ABBVIE INC. | 3 | $71 |
| GlaxoSmithKline, LLC. | 2 | $60 |
| Amgen Inc. | 2 | $47 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, LEQVIO, LINZESS, OTEZLA, ENTRESTO, CREON, FUROSCIX, EVENITY.
Industry payments across CA — which companies pay providers there.
